JWK 008
Alternative Names: JWK-008Latest Information Update: 31 Jul 2024
At a glance
- Originator Chengdu Jinweike Biotechnology
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Mucopolysaccharidosis I
Most Recent Events
- 22 Jul 2024 Phase-I clinical trials in Mucopolysaccharidosis I in China (IV) (NCT06519552)
- 11 Apr 2024 Preclinical trials in mucopolysaccharidosis-I in China (Parenteral), prior to April 2024 (Chengdu Jinweike Biotechnology pipeline, April 2024)